Literature DB >> 32664792

Sliding Scoring of the Glasgow Outcome Scale-Extended as Primary Outcome in Traumatic Brain Injury Trials.

Sharon D Yeatts1, Reneé H Martin1, William Meurer2,3, Robert Silbergleit2, Gaylan L Rockswold4, William G Barsan2, Frederick K Korley2, David W Wright5, Byron J Gajewski6.   

Abstract

The Glasgow Outcome Scale-Extended (GOS-E), an ordinal scale measuring global outcome, is used commonly as the primary outcome measure in clinical trials of traumatic brain injury. Analysis is often based on a dichotomization and thus has inherent statistical limitations, including loss of information related to the collapse of adjacent categories. A fixed dichotomization defines favorable outcome consistently for all subjects, whereas a sliding dichotomy tailors the definition of favorable outcome according to baseline prognosis/severity. Literature indicates that the sliding dichotomy is more statistically efficient than the fixed dichotomy; however, the sliding dichotomy still collapses categories and therefore discards information. We propose an alternative, a sliding scoring system for the GOS-E, intended to address the limitations of the sliding dichotomy. The score is assigned based on the number of levels between the achieved score and the favorable cut-point. The proposed scoring system reflects the magnitude of change, where change is defined according to each subject's baseline prognosis. Because the score is approximately continuous, statistical methods can rely on the normal distribution, both for analysis and study design. Two examples show the corresponding potential for improved power. A sliding score approach allows for quantification of the magnitude of change while still accounting for prognosis. Scientific advantages include increased power and an intuitive interpretation.

Entities:  

Keywords:  Glasgow Outcome Scale-Extended; sliding score; statistical analysis

Mesh:

Year:  2020        PMID: 32664792      PMCID: PMC7757546          DOI: 10.1089/neu.2019.6969

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  11 in total

1.  Does the extended Glasgow Outcome Scale add value to the conventional Glasgow Outcome Scale?

Authors:  James Weir; Ewout W Steyerberg; Isabella Butcher; Juan Lu; Hester F Lingsma; Gillian S McHugh; Bob Roozenbeek; Andrew I R Maas; Gordon D Murray
Journal:  J Neurotrauma       Date:  2012-01-01       Impact factor: 5.269

Review 2.  The cost of dichotomising continuous variables.

Authors:  Douglas G Altman; Patrick Royston
Journal:  BMJ       Date:  2006-05-06

3.  A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the IMPACT Project.

Authors:  Gillian S McHugh; Isabella Butcher; Ewout W Steyerberg; Anthony Marmarou; Juan Lu; Hester F Lingsma; James Weir; Andrew I R Maas; Gordon D Murray
Journal:  Clin Trials       Date:  2010-02       Impact factor: 2.486

4.  Comparative study of outcome measures and analysis methods for traumatic brain injury trials.

Authors:  Aziz S Alali; Darcy Vavrek; Jason Barber; Sureyya Dikmen; Avery B Nathens; Nancy R Temkin
Journal:  J Neurotrauma       Date:  2015-02-09       Impact factor: 5.269

5.  Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension.

Authors:  Peter J Hutchinson; Angelos G Kolias; Ivan S Timofeev; Elizabeth A Corteen; Marek Czosnyka; Jake Timothy; Ian Anderson; Diederik O Bulters; Antonio Belli; C Andrew Eynon; John Wadley; A David Mendelow; Patrick M Mitchell; Mark H Wilson; Giles Critchley; Juan Sahuquillo; Andreas Unterberg; Franco Servadei; Graham M Teasdale; John D Pickard; David K Menon; Gordon D Murray; Peter J Kirkpatrick
Journal:  N Engl J Med       Date:  2016-09-07       Impact factor: 91.245

6.  Bayesian hierarchical EMAX model for dose-response in early phase efficacy clinical trials.

Authors:  Byron J Gajewski; Caitlyn Meinzer; Scott M Berry; Gaylan L Rockswold; William G Barsan; Frederick K Korley; Renee' H Martin
Journal:  Stat Med       Date:  2019-05-09       Impact factor: 2.373

Review 7.  Design and analysis of phase III trials with ordered outcome scales: the concept of the sliding dichotomy.

Authors:  Gordon D Murray; David Barer; Sung Choi; Helen Fernandes; Barbara Gregson; Kennedy R Lees; Andrew I R Maas; Anthony Marmarou; A David Mendelow; Ewout W Steyerberg; Gillian S Taylor; Graham M Teasdale; Christopher J Weir
Journal:  J Neurotrauma       Date:  2005-05       Impact factor: 5.269

8.  Very early administration of progesterone for acute traumatic brain injury.

Authors:  David W Wright; Sharon D Yeatts; Robert Silbergleit; Yuko Y Palesch; Vicki S Hertzberg; Michael Frankel; Felicia C Goldstein; Angela F Caveney; Harriet Howlett-Smith; Erin M Bengelink; Geoffrey T Manley; Lisa H Merck; L Scott Janis; William G Barsan
Journal:  N Engl J Med       Date:  2014-12-10       Impact factor: 91.245

9.  The added value of ordinal analysis in clinical trials: an example in traumatic brain injury.

Authors:  Bob Roozenbeek; Hester F Lingsma; Pablo Perel; Phil Edwards; Ian Roberts; Gordon D Murray; Andrew Ir Maas; Ewout W Steyerberg
Journal:  Crit Care       Date:  2011-05-17       Impact factor: 9.097

10.  Utility-Weighted Modified Rankin Scale as Primary Outcome in Stroke Trials: A Simulation Study.

Authors:  Simone A Dijkland; Daphne C Voormolen; Esmee Venema; Bob Roozenbeek; Suzanne Polinder; Juanita A Haagsma; Daan Nieboer; Vicky Chalos; Albert J Yoo; Jennifer Schreuders; Aad van der Lugt; Charles B L M Majoie; Yvo B W E M Roos; Wim H van Zwam; Robert J van Oostenbrugge; Ewout W Steyerberg; Diederik W J Dippel; Hester F Lingsma
Journal:  Stroke       Date:  2018-03-13       Impact factor: 7.914

View more
  5 in total

1.  Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study.

Authors:  Frederick K Korley; Sonia Jain; Xiaoying Sun; Ava M Puccio; John K Yue; Raquel C Gardner; Kevin K W Wang; David O Okonkwo; Esther L Yuh; Pratik Mukherjee; Lindsay D Nelson; Sabrina R Taylor; Amy J Markowitz; Ramon Diaz-Arrastia; Geoffrey T Manley
Journal:  Lancet Neurol       Date:  2022-09       Impact factor: 59.935

2.  Effect of tranexamic acid on the prognosis of patients with traumatic brain injury undergoing craniotomy: study protocol for a randomised controlled trial.

Authors:  Yu Lu; Weihua Cui; Bei Wu; Yun Yu; Hongli Yue; Jie Wang; Yingzi Chong
Journal:  BMJ Open       Date:  2021-11-25       Impact factor: 2.692

3.  Effect of Different Nursing Interventions on Discharged Patients with Cardiac Valve Replacement Evaluated by Deep Learning Algorithm-Based MRI Information.

Authors:  Jing Zhang; Qiong Zhou
Journal:  Contrast Media Mol Imaging       Date:  2022-03-21       Impact factor: 3.161

4.  Altered Intestinal Microbiomes and Lipid Metabolism in Patients With Prolonged Disorders of Consciousness.

Authors:  Jie Yu; Qisheng Cheng; Fangping He; Fanxia Meng; Yamei Yu; Chuan Xu; Xinrui Wen; Lirong Hong; Jian Gao; Jingqi Li; Gang Pan; Ming D Li; Benyan Luo
Journal:  Front Immunol       Date:  2022-07-13       Impact factor: 8.786

5.  Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness.

Authors:  Jan Claassen; Yama Akbari; Sheila Alexander; Mary Kay Bader; Kathleen Bell; Thomas P Bleck; Melanie Boly; Jeremy Brown; Sherry H-Y Chou; Michael N Diringer; Brian L Edlow; Brandon Foreman; Joseph T Giacino; Olivia Gosseries; Theresa Green; David M Greer; Daniel F Hanley; Jed A Hartings; Raimund Helbok; J Claude Hemphill; H E Hinson; Karen Hirsch; Theresa Human; Michael L James; Nerissa Ko; Daniel Kondziella; Sarah Livesay; Lori K Madden; Shraddha Mainali; Stephan A Mayer; Victoria McCredie; Molly M McNett; Geert Meyfroidt; Martin M Monti; Susanne Muehlschlegel; Santosh Murthy; Paul Nyquist; DaiWai M Olson; J Javier Provencio; Eric Rosenthal; Gisele Sampaio Silva; Simone Sarasso; Nicholas D Schiff; Tarek Sharshar; Lori Shutter; Robert D Stevens; Paul Vespa; Walter Videtta; Amy Wagner; Wendy Ziai; John Whyte; Elizabeth Zink; Jose I Suarez
Journal:  Neurocrit Care       Date:  2021-07-08       Impact factor: 3.210

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.